Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment
Rating
Fund
Time to Invest
Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment
NAV
173.7667
(22/09/2023)
L 52Wk H
133.74
177.49
Login using to know what your Friends are Investing !

Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment
Fund
NAV
173.7667
(22/09/2023)
Time to Invest
Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment
Rating
L 52Wk H
133.74
177.49

Asset Allocation for Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

Top 10 Holdings of Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

64.29 % of total assets
Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd.(13.67%)
Cipla Ltd.Cipla Ltd.(8.66%)
Divi's Laboratories Ltd.Divi's Laboratories Ltd.(7.07%)
Aether Industries Ltd.Aether Industries Ltd.(7.07%)
Max Healthcare Institute Ltd.Max Healthcare Institute Ltd.(5.22%)
Mankind Pharma Ltd.Mankind Pharma Ltd.(4.97%)
Krishna Institute of Medical Sciences Ltd.Krishna Institute of Medical Sciences Ltd.(4.72%)
Gland Pharma Ltd.Gland Pharma Ltd.(4.56%)
Global Health Ltd.Global Health Ltd.(4.19%)
Rainbow Children's Medicare Ltd.Rainbow Children's Medicare Ltd.(4.17%)

Detailed Portfolio of Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

Portfolio Date -31 Aug 2023
Equity Holdings -23
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Ltd. 13.67% 277.900 Cr
Cipla Ltd. 8.66% 176.064 Cr
Divi's Laboratories Ltd. 7.07% 143.684 Cr
Aether Industries Ltd. 7.07% 143.661 Cr
Max Healthcare Institute Ltd. 5.22% 106.119 Cr
Mankind Pharma Ltd. 4.97% 100.962 Cr
Krishna Institute of Medical Sciences Ltd. 4.72% 95.918 Cr
Gland Pharma Ltd. 4.56% 92.732 Cr
Global Health Ltd. 4.19% 85.134 Cr
Rainbow Children's Medicare Ltd. 4.17% 84.756 Cr
Alkem Laboratories Ltd. 4.12% 83.786 Cr
Fortis Healthcare Ltd. 3.43% 69.647 Cr
Lupin Ltd. 3.24% 65.871 Cr
Aurobindo Pharma Ltd. 3.06% 62.250 Cr
Abbott India Ltd. 2.84% 57.774 Cr
JB Chemicals & Pharmaceuticals Ltd. 2.72% 55.370 Cr -
Biocon Ltd. 2.68% 54.464 Cr
Torrent Pharmaceuticals Ltd. 2.54% 51.590 Cr
Zydus Lifesciences Ltd. 2.16% 43.810 Cr
Laurus Labs Ltd. 1.57% 31.968 Cr
Ami Organics Ltd. 1.55% 31.573 Cr
Gufic Biosciences Ltd. 1.52% 30.940 Cr
Jupiter Life Line Hospitals Ltd. 0.72% 14.700 Cr -
Holdings % Weight Value Sahi Hai/Nahi
TREPS 3.28% 66.723 Cr -
Shreno Ltd. 0.34% 6.835 Cr
Net Receivable / Payable -0.06% -1.276 Cr -

Insight on the composition of the Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment

Style Box of the Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment

Portfolio Characteristics of the Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment Fund Growth

Sbi Healthcare Opportunities Fund Regular Idcw Reinvestment